
Dale R. Miller
Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 838 |
| Issued Applications | 502 |
| Pending Applications | 84 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10481880
[patent_doc_number] => 20150366898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'METHODS FOR TREATING OVERWEIGHT OR OBESITY'
[patent_app_type] => utility
[patent_app_number] => 14/744506
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10162
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14744506
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/744506 | Methods for treating overweight or obesity | Jun 18, 2015 | Issued |
Array
(
[id] => 15466115
[patent_doc_number] => 10548911
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Small molecule anti-scarring agents
[patent_app_type] => utility
[patent_app_number] => 15/319254
[patent_app_country] => US
[patent_app_date] => 2015-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 36
[patent_no_of_words] => 26849
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319254
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/319254 | Small molecule anti-scarring agents | Jun 15, 2015 | Issued |
Array
(
[id] => 11662569
[patent_doc_number] => 20170151275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'THE USE OF DEXTRAN SULFATE HAVING AN AVERAGE MOLECULAR WEIGHT BELOW 10000 DA FOR INDUCING ANGIOGENESIS IN A SUBJECT'
[patent_app_type] => utility
[patent_app_number] => 15/316789
[patent_app_country] => US
[patent_app_date] => 2015-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 14996
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316789
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/316789 | Use of dextran sulfate having an average molecular weight below 10000 DA for inducing angiogenesis in a subject | Jun 10, 2015 | Issued |
Array
(
[id] => 10380637
[patent_doc_number] => 20150265645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'Composition For Prevention, Amelioration Or Treatment Of Metabolic Syndrome'
[patent_app_type] => utility
[patent_app_number] => 14/733592
[patent_app_country] => US
[patent_app_date] => 2015-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6087
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14733592
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/733592 | Composition for prevention, amelioration or treatment of metabolic syndrome | Jun 7, 2015 | Issued |
Array
(
[id] => 11821892
[patent_doc_number] => 20170210829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'CROSS-LINKED POLYMER MIXTURE OF HYALURONIC ACID AND DEXTRAN GRAFTED WITH CYCLODEXTRINS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/314795
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7728
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314795
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314795 | CROSS-LINKED POLYMER MIXTURE OF HYALURONIC ACID AND DEXTRAN GRAFTED WITH CYCLODEXTRINS AND USES THEREOF | May 28, 2015 | Abandoned |
Array
(
[id] => 11742918
[patent_doc_number] => 20170196991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'CYCLODEXTRIN-GRAFTED HYALURONIC ACID CROSSLINKED WITH DEXTRAN AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/314823
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7343
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314823
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314823 | CYCLODEXTRIN-GRAFTED HYALURONIC ACID CROSSLINKED WITH DEXTRAN AND USES THEREOF | May 28, 2015 | Abandoned |
Array
(
[id] => 11834624
[patent_doc_number] => 20170216343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'VISCOSUPPLEMENT COMPOSITION COMPRISING ULVAN FOR TREATING ARTHRITIS'
[patent_app_type] => utility
[patent_app_number] => 15/311779
[patent_app_country] => US
[patent_app_date] => 2015-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6431
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15311779
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/311779 | VISCOSUPPLEMENT COMPOSITION COMPRISING ULVAN FOR TREATING ARTHRITIS | May 17, 2015 | Abandoned |
Array
(
[id] => 12641334
[patent_doc_number] => 20180105609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => PREPARATION OF WATER SOLUBLE TRIVALENT IRON CARBOHYDRATE COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 15/559976
[patent_app_country] => US
[patent_app_date] => 2015-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559976
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/559976 | PREPARATION OF WATER SOLUBLE TRIVALENT IRON CARBOHYDRATE COMPLEXES | May 5, 2015 | Abandoned |
Array
(
[id] => 11455893
[patent_doc_number] => 20170049796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'ADMINISTRATION OF CITICOLINE TO IMPROVE COGNITIVE PERFORMANCE, ATTENTIONAL PERFORMANCE, AND MOTOR FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 15/307411
[patent_app_country] => US
[patent_app_date] => 2015-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 27526
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15307411
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/307411 | Administration of citicoline to improve cognitive performance, attentional performance, and motor function | Apr 29, 2015 | Issued |
Array
(
[id] => 11455890
[patent_doc_number] => 20170049797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'COMBINATION THERAPY FOR TREATING HCV INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/307428
[patent_app_country] => US
[patent_app_date] => 2015-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5849
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15307428
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/307428 | COMBINATION THERAPY FOR TREATING HCV INFECTION | Apr 29, 2015 | Abandoned |
Array
(
[id] => 11002542
[patent_doc_number] => 20160199491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'Compounds compositions and methods including thermally labile moieties'
[patent_app_type] => utility
[patent_app_number] => 14/545280
[patent_app_country] => US
[patent_app_date] => 2015-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23679
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14545280
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/545280 | Compounds compositions and methods including thermally labile moieties | Apr 14, 2015 | Abandoned |
Array
(
[id] => 16351802
[patent_doc_number] => 10792294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
[patent_app_type] => utility
[patent_app_number] => 15/302793
[patent_app_country] => US
[patent_app_date] => 2015-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 5379
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15302793
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/302793 | Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides | Apr 2, 2015 | Issued |
Array
(
[id] => 11554176
[patent_doc_number] => 20170100422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'Solid Composition Comprising Amorphous Sofosbuvir'
[patent_app_type] => utility
[patent_app_number] => 15/129149
[patent_app_country] => US
[patent_app_date] => 2015-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 24473
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15129149
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/129149 | Solid composition comprising amorphous sofosbuvir | Apr 1, 2015 | Issued |
Array
(
[id] => 11401756
[patent_doc_number] => 20170022295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'CHONDROITIN SULPHATE PURIFICATION METHOD'
[patent_app_type] => utility
[patent_app_number] => 15/124675
[patent_app_country] => US
[patent_app_date] => 2015-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9272
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15124675
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/124675 | Chondroitin sulphate purification method | Mar 19, 2015 | Issued |
Array
(
[id] => 11930037
[patent_doc_number] => 09797021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Compositions comprising C5 and C6 oligosaccharides'
[patent_app_type] => utility
[patent_app_number] => 14/660988
[patent_app_country] => US
[patent_app_date] => 2015-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10877
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14660988
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/660988 | Compositions comprising C5 and C6 oligosaccharides | Mar 17, 2015 | Issued |
Array
(
[id] => 11915683
[patent_doc_number] => 09783860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'Compositions comprising C5 and C6 oligosaccharides'
[patent_app_type] => utility
[patent_app_number] => 14/661000
[patent_app_country] => US
[patent_app_date] => 2015-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10771
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14661000
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/661000 | Compositions comprising C5 and C6 oligosaccharides | Mar 17, 2015 | Issued |
Array
(
[id] => 11497911
[patent_doc_number] => 20170072096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'NOVEL HYDROGELS AND METHODS USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/120824
[patent_app_country] => US
[patent_app_date] => 2015-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7868
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15120824
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/120824 | NOVEL HYDROGELS AND METHODS USING SAME | Mar 15, 2015 | Abandoned |
Array
(
[id] => 11393911
[patent_doc_number] => 20170014446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'COMPOSITIONS AND METHODS FOR ADMINISTERING GALECTIN ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/125051
[patent_app_country] => US
[patent_app_date] => 2015-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 29677
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15125051
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/125051 | COMPOSITIONS AND METHODS FOR ADMINISTERING GALECTIN ANTAGONISTS | Mar 9, 2015 | Abandoned |
Array
(
[id] => 14759469
[patent_doc_number] => 10391113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Compatible composition containing chinese medicine cichorium glandulosum boiss et hout as lipid-lowering active ingredient
[patent_app_type] => utility
[patent_app_number] => 15/308852
[patent_app_country] => US
[patent_app_date] => 2015-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3791
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308852
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/308852 | Compatible composition containing chinese medicine cichorium glandulosum boiss et hout as lipid-lowering active ingredient | Mar 5, 2015 | Issued |
Array
(
[id] => 14662577
[patent_doc_number] => 10369165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-06
[patent_title] => Composition containing active components of
[patent_app_type] => utility
[patent_app_number] => 15/531763
[patent_app_country] => US
[patent_app_date] => 2015-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4142
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15531763
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/531763 | Composition containing active components of | Mar 5, 2015 | Issued |